| abstract |
The present invention relates to a salt of compounds or their pharmaceutically acceptable represented by the following structural formula 1, the solvent compound (solvate), inclusion compound (clathrate) or bulb Ca in a cell by administering a drug (prodrug) 2 + - release-activated Ca 2 + Channel (Ca 2 + -release-activated Ca 2 + channel, CRAC). X, Y, A, Z, L and n are defined herein.n n n <Structure 1>n n n n n n n n n Immunosuppressants, inflammatory conditions, immune disorders, calcium ion channels |